These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12795180)

  • 1. [The efficacy of switch therapy in community-acquired pneumonia in Japan].
    Uchiyama N; Aoshima M; Satoh T; Chonabayashi N
    Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):261-7. PubMed ID: 12795180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.
    Carratalà J; Garcia-Vidal C; Ortega L; Fernández-Sabé N; Clemente M; Albero G; López M; Castellsagué X; Dorca J; Verdaguer R; Martínez-Montauti J; Manresa F; Gudiol F
    Arch Intern Med; 2012 Jun; 172(12):922-8. PubMed ID: 22732747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
    Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
    Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of processes and outcomes of pneumonia care between hospitalists and community-based primary care physicians.
    Rifkin WD; Conner D; Silver A; Eichorn A
    Mayo Clin Proc; 2002 Oct; 77(10):1053-8. PubMed ID: 12374249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.
    Ramirez JA; Srinath L; Ahkee S; Huang A; Raff MJ
    Arch Intern Med; 1995 Jun; 155(12):1273-6. PubMed ID: 7778957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of clinical pathway for community-acquired pneumonia as both an educational and a cost-management tool--an intervention study to compare the usefulness of management with a critical pathway to historical control of conventional management].
    Aoshima M; Satoh T; Uchiyama N; Chonabayashi N
    Nihon Kokyuki Gakkai Zasshi; 2002 Aug; 40(8):644-52. PubMed ID: 12428392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P;
    Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy].
    Fernández P; San Martín L
    Rev Med Chil; 2000 Mar; 128(3):267-72. PubMed ID: 10962867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.
    Castro-Guardiola A; Viejo-Rodríguez AL; Soler-Simon S; Armengou-Arxé A; Bisbe-Company V; Peñarroja-Matutano G; Bisbe-Company J; García-Bragado F
    Am J Med; 2001 Oct; 111(5):367-74. PubMed ID: 11583639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of clinical pathway management on pediatric pneumonia].
    Yang Y; Yin LJ; Peng DH; Huang Y; Dai JH
    Zhonghua Er Ke Za Zhi; 2013 Oct; 51(10):793-7. PubMed ID: 24406236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
    Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of early switch from intravenous to oral antimicrobials in patients with aspiration pneumonia: A prospective observational study.
    Uni M; Nishimura N; Yamano Y; Ishikawa G; Kitamura A; Tomishima Y; Jinta T; Takahashi O; Deshpande G; Chohnabayashi N
    Respir Investig; 2015 Sep; 53(5):225-31. PubMed ID: 26344612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
    el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
    BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study.
    Fine MJ; Medsger AR; Stone RA; Marrie TJ; Coley CM; Singer DE; Akkad H; Hough LJ; Lang W; Ricci EM; Polenik DM; Kapoor WN
    Arch Intern Med; 1997 Jan; 157(1):47-56. PubMed ID: 8996040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declining length of hospital stay for pneumonia and postdischarge outcomes.
    Capelastegui A; España PP; Quintana JM; Gallarreta M; Gorordo I; Esteban C; Urrutia I; Bilbao A
    Am J Med; 2008 Oct; 121(10):845-52. PubMed ID: 18823851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK; Nopmaneejumruslers C; Chan CK
    Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia.
    Ramirez JA; Vargas S; Ritter GW; Brier ME; Wright A; Smith S; Newman D; Burke J; Mushtaq M; Huang A
    Arch Intern Med; 1999 Nov; 159(20):2449-54. PubMed ID: 10665893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.